CEO Jason A Okazaki sells $121,658 of Assembly Biosciences, Inc. stock
The CEO sold at an average of $19.62 a share, according to a Form 4 filed with the SEC on Nov 3.
A Form 4 filed on Nov 3 shows Jason A Okazaki (CEO) selling 6,202 Assembly Biosciences, Inc. shares worth about $120,000 on Nov 2.
The filing does not mark the sale as made under a Rule 10b5-1 trading plan. Four Assembly Biosciences, Inc. insiders sold on the open market within 14 days, a pattern known as a cluster sell.
After the trade, the filing lists 195,532 shares held. The trade was reported within two business days, as Section 16 requires.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Assembly Biosciences, Inc. (ASMB) |
|---|---|
| Insider | Jason A Okazaki |
| Role | CEO |
| Transaction | Open-market sale (code S) |
| Shares | 6,202 |
| Average price | $19.62 |
| Value | $121,658 |
| Trade date | Nov 2, 2026 |
| Filed with the SEC | Nov 3, 2026, 4:30 PM ET |
| Shares held after | 195,532 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See more details on this insider sale
Browse the latest insider selling · See the latest cluster buys and sells
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
